secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001493152-24-027072
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis acquires CAR-T IP from Broaden for up to $11M, net of $10.8M debt
---------------------------------------------------------------------------

- Orgenesis buys Broaden's CAR-T, RACE CAR-T process and algorithms, including patents and know-how.
- Consideration capped at $11M, reduced by $10.767M debt Broaden owes Orgenesis for prior work.
- Net consideration (if any) payable in Orgenesis stock at $3/share or 10% above market, or a 24-month note.
- Broaden contracts with Orgenesis Maryland for exclusive perpetual cell therapy processing services.
- All rights under the Dec 2022 JVA, including JV entity shares, transferred to Orgenesis free of charge.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224027072/0001493152-24-027072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224027072/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-027072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer